or
forgot password
  • cancer clinical trials in rochester, NY

  • Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lipson Cancer and Blood Center at Rochester General Hospital
    Genesee Surgical Associates - Linden Oaks Medical Campus
    Breast Cancer
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    University Radiation Oncology at Parkridge Hospital
    Rochester, New York 14626
    Prostate Cancer
    S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Multiple Myeloma, Plasma Cell Myeloma
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Lipson Cancer and Blood Center at Rochester General Hospital
    Rochester, New York 14621
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Lipson Cancer and Blood Center at Rochester General Hospital
    Rochester, New York 14621
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Kidney Cancer
    Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Bladder Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Lipson Cancer and Blood Center at Rochester General Hospital
    Rochester, New York 14621
    Colorectal Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lipson Cancer and Blood Center at Rochester General Hospital
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Lipson Cancer and Blood Center at Rochester General Hospital

    Trial Locations
    Lipson Cancer and Blood Center at Rochester General Hospital
    University Radiation Oncology at Parkridge Hospital
    Breast Cancer
    A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    University of Rochester Medical Center
    Rochester, New York 14642
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lymphoma
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Rochester
    Rochester, New York 14642
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Metastatic Cancer, Prostate Cancer
    Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Carcinoma, Non-Small-Cell Lung
    Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Brain Neoplasm
    Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
    University of Rochester, James P. Wilmot Cancer Center
    Rochester, New York 14642
    Cancer, Fatigue, Chemotherapy
    Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
    University of Rochester
    Rochester, New York 14642
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Rochester General Hospital

    Trial Locations
    Rochester General Hospital
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Interlakes Oncology Hematology, PC
    Rochester, New York 14623
    Metastatic Breast Cancer
    Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy in Treating Patients With Liver Metastases
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Metastatic Cancer
    Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Bortezomib in Treating Patients With Myelodysplastic Syndromes
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Myelodysplastic Syndromes
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Colorectal Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Prostate Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Rochester
    Rochester, New York 14642
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Rochester General Hospital

    Trial Locations
    Rochester General Hospital
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer